Assets in USD of Context Therapeutics Inc. from Q4 2020 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Context Therapeutics Inc. quarterly Assets history and change rate from Q4 2020 to Q3 2025.
Context Therapeutics Inc. Assets for the quarter ending 30 Sep 2025 was $79.2M, a 8.22% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Change (%)

Context Therapeutics Inc. Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$79.2M	-$7.1M	-8.22%	30 Sep 2025	10-Q	05 Nov 2025
Q2 2025	$87.2M	-$15.6M	-15.1%	30 Jun 2025	10-Q	06 Aug 2025
Q1 2025	$93M	+$81.9M	+741%	31 Mar 2025	10-Q	07 May 2025
Q4 2024	$98.1M	+$82.1M	+511%	31 Dec 2024	10-Q	05 Nov 2025
Q3 2024	$86.3M	+$63.3M	+276%	30 Sep 2024	10-Q	06 Nov 2024
Q2 2024	$103M	+$74.9M	+270%	30 Jun 2024	10-Q	07 Aug 2024
Q1 2024	$11.1M	-$20.9M	-65.4%	31 Mar 2024	10-Q	08 May 2024
Q4 2023	$16.1M	-$21.9M	-57.7%	31 Dec 2023	10-K	20 Mar 2025
Q3 2023	$23M	-$19.1M	-45.4%	30 Sep 2023	10-Q	09 Nov 2023
Q2 2023	$27.8M	-$16.9M	-37.9%	30 Jun 2023	10-Q	09 Aug 2023
Q1 2023	$32M	-$15.1M	-32%	31 Mar 2023	10-Q	10 May 2023
Q4 2022	$38M	-$13.3M	-26%	31 Dec 2022	10-K	21 Mar 2024
Q3 2022	$42.1M	+$39.8M	+1763%	30 Sep 2022	10-Q	09 Nov 2022
Q2 2022	$44.7M			30 Jun 2022	10-Q	11 Aug 2022
Q1 2022	$47M			31 Mar 2022	10-Q	11 May 2022
Q4 2021	$51.3M	+$50.8M	+10878%	31 Dec 2021	10-K	22 Mar 2023
Q3 2021	$2.26M			30 Sep 2021	10-Q	02 Dec 2021
Q4 2020	$467K			31 Dec 2020	10-K	23 Mar 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.